- Home
- DEA vs INMD Comparison
DEA vs INMD Comparison
Compare DEA & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DEA
- INMD
- Stock Information
- Founded
- DEA 2011
- INMD 2008
- Country
- DEA United States
- INMD Israel
- Employees
- DEA N/A
- INMD N/A
- Industry
- DEA Real Estate Investment Trusts
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DEA Real Estate
- INMD Health Care
- Exchange
- DEA Nasdaq
- INMD Nasdaq
- Market Cap
- DEA 1.0B
- INMD 896.9M
- IPO Year
- DEA 2015
- INMD 2019
- Fundamental
- Price
- DEA $22.79
- INMD $15.07
- Analyst Decision
- DEA Hold
- INMD Hold
- Analyst Count
- DEA 5
- INMD 6
- Target Price
- DEA $27.15
- INMD $16.81
- AVG Volume (30 Days)
- DEA 593.9K
- INMD 984.1K
- Earning Date
- DEA 11-04-2025
- INMD 10-29-2025
- Dividend Yield
- DEA 7.88%
- INMD N/A
- EPS Growth
- DEA N/A
- INMD 46.63
- EPS
- DEA 0.38
- INMD 2.54
- Revenue
- DEA $322,861,000.00
- INMD $401,561,000.00
- Revenue This Year
- DEA $8.78
- INMD N/A
- Revenue Next Year
- DEA $6.43
- INMD $5.30
- P/E Ratio
- DEA $60.46
- INMD $5.96
- Revenue Growth
- DEA 7.93
- INMD N/A
- 52 Week Low
- DEA $19.33
- INMD $13.14
- 52 Week High
- DEA $36.31
- INMD $19.85
- Technical
- Relative Strength Index (RSI)
- DEA 52.30
- INMD 56.98
- Support Level
- DEA $22.40
- INMD $14.28
- Resistance Level
- DEA $23.54
- INMD $15.30
- Average True Range (ATR)
- DEA 0.53
- INMD 0.38
- MACD
- DEA 0.07
- INMD 0.05
- Stochastic Oscillator
- DEA 56.14
- INMD 74.38
About DEA Easterly Government Properties Inc.
Easterly Government Properties Inc is a real estate investment trust. It is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. The company generates all its revenue by leasing its properties to such agencies.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.